Drug Shortage Report for CARBOLITH
Report ID | 232669 |
Drug Identification Number | 00236683 |
Brand name | CARBOLITH |
Common or Proper name | CARBOLITH |
Company Name | BAUSCH HEALTH, CANADA INC. |
Market Status | MARKETED |
Active Ingredient(s) | LITHIUM CARBONATE |
Strength(s) | 300MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL ORAL |
Packaging sizes (GTIN)
Click here to see a list of all reports for this drug. |
(See additional packaging sizes) |
Additional packaging sizes | 100's |
ATC code | N05AN |
ATC description | ANTIPSYCHOTICS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2024-09-18 |
Actual start date | 2024-09-16 |
Estimated end date | 2024-09-26 |
Actual end date | 2024-09-24 |
Shortage status | Resolved |
Updated date | 2024-09-25 |
Company comments | |
Health Canada comments | |
Tier 3 Status | Yes |
Contact Address | 2150 BOUL. ST-ELZEAR OUEST LAVAL, QUEBEC CANADA H7L 4A8 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v11 | 2024-09-25 | French | Compare |
v10 | 2024-09-25 | English | Compare |
v9 | 2024-09-18 | French | Compare |
v8 | 2024-09-18 | English | Compare |
v7 | 2024-09-11 | French | Compare |
v6 | 2024-09-11 | English | Compare |
v5 | 2024-08-06 | English | Compare |
v4 | 2024-07-17 | French | Compare |
v3 | 2024-07-17 | English | Compare |
v2 | 2024-07-11 | French | Compare |
v1 | 2024-07-11 | English | Compare |
Showing 1 to 11 of 11